 Approximately 1250 patients over 18 years of age approximately 50 menwomen, with metastatic NSCLC, who are going to commence first-line treatment and who have a life expectancy of over three months will be included. They will be distributed into two cohorts men and women at 50 and will be distributed by age group and smoking status to facilitate the homogeneity between the two cohorts. 